Dr. Asa Tapley is an internal medicine physician specialized in the prevention, diagnosis, and treatment of infectious diseases. He is passionate about providing clinical care for and conducting research and advocacy in support of poor and marginalized communities. He has over a decade of diverse research experience related to tuberculosis (TB), ranging from lab-based basic and pre-clinical research to clinical and implementation studies. While continuing to be engaged in TB research, more recently Dr. Tapley has been involved in vaccine clinical trials based in sub-Saharan Africa through his association with the Fred Hutchison Cancer Center's Vaccine and Infectious Diseases Division (VIDD) and the HIV Vaccine Trials Network (HVTN) and COVID-19 Prevention Network (CoVPN). Although often based in South Africa, he continues to see patients in Seattle.
- Research related to improving prevention, diagnosis, and treatment of tuberculosis, especially among individuals living with HIV.
- Clinical trials of novel vaccines for SARS-CoV-2, HIV, and tuberculosis.
- tuberculosis and other mycobacterial diseases
- infectious complications of IV drug use
Education & Training
Fellow, Division of Allergy and Infectious Diseases, University of Washington Medical Center, Seattle, 2019-2022
Resident, Internal Medicine Residency, Johns Hopkins Bayview Medical Center, Baltimore, 2015-2018
M.D. with Distinction in Clinical & Translational Research, University of California San Francisco School of Medicine, 2015
International Pilot Award, UW/Fred Hutch Center for AIDS Research, 2021
Alpha Omega Alpha (AOA), Johns Hopkins Medicine, 2018
Paul S. Lietman Global Travel Fellowship, Johns Hopkins Medicine, South Africa, 2018
Dean’s Prize for Research & Scholarship, UCSF School of Medicine, 2015
Howard Hughes Medical Institute Medical Research Fellowship, South Africa, 2013-2014
Fulbright Scholarship, Peru, 2008-2009